Skip to search formSkip to main contentSkip to account menu

24 HR rivastigmine 0.192 MG/HR Transdermal System

Known as: RIVASTIGMINE 4.6 mg in 24 h TRANSDERMAL PATCH, EXTENDED RELEASE [Rivastigmine], rivastigmine 4.6 MG/Day 24 HR Transdermal Patch, rivastigmine 0.192 MG/HR 24 HR Transdermal Patch 
National Institutes of Health

Related topics

Related topics

9 relations

Narrower (1)

24 HR rivastigmine 0.192 MG/HR Transdermal System [Exelon]
Alzheimer's DiseaseCarbamatesHypersensitivityMineral Oil, Light

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2019
Highly Cited
2019
Apigenin-rivastigmine hybrids as multi-target-directed liagnds for the treatment of Alzheimer's disease.
2019
2019
Hypoxic-conditioned medium from adipose tissue mesenchymal stem cells improved neuroinflammation through alternation of toll like receptor (TLR) 2 and TLR4 expression in model of Alzheimer's disease…
2019
2019
Behavioral and Biochemical Implications of Dendrimeric Rivastigmine in Memory-Deficit and Alzheimer's Induced Rodents.
Exploration of dendrimers for effective drug delivery is giving promising results. The present study was designed and performed… 
2016
2016
Stability-indicating high performance liquid chromatographic determination of rivastigmine with kinetic study of rivastigmine alkalinedegradation
Stability-indicating high performance liquid chromatographic determination of rivastigmine in its binary mixture with kinetic… 
2014
2014
Novel L-lactide-depsipeptide polymeric carrier for enhanced brain uptake of rivastigmine in treatment of Alzheimer's disease.
The present study discusses possibility of targeting an anti-Alzheimer's drug rivastigmine tartarate (RT) to the brain using… 
2010
2010
Galantamine of rivastigmine pleister. Een beschrijvend onderzoek op een geheugenpolikliniek in Nederland
SamenvattingDoel van onderzoek In Nederland zijn vanaf januari 2008 twee eenmaaldaags toe te dienen cholinesteraseremmers… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)